Alembic Pharma’s Q2FY24 Quarter Results
Alembic Pharma’s revenues grew over 9% YoY
- 09 Nov 2023
- Alembic Pharma reported 7% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter ended September (Q2FY24). On a year-on-year (YoY) basis, it witnessed a growth of 9%.
- Its expenses for the quarter were up by 7% QoQ and 11% YoY.
- The net profit grew 13% QoQ and 2% YoY.
- The earnings per share (EPS) of Alembic Pharma stood at 7 during Q2FY24.
Alembic Pharma’s Financial Statements for Q2FY24:
| (Rs crores) | Q2FY23 | Q1FY24 | Q2FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total income | 1,475 | 1,498 | 1,605 | 7% | 9% |
Total expenses | 1,322 | 1,368 | 1,470 | 7% | 11% |
Profit before tax | 151 | 130 | 135 | 4% | -11% |
Tax | 18 | 9 | -2 | - | - |
Profit after tax | 133 | 121 | 137 | 13% | 2% |
Earnings per share | 6.8 | 6.1 | 7.0 |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Open Demat Account
